Development and preliminary evaluation of the Conventional Medicine Disclosure Index.

McIntyre, E; Foley, H; Harnett, J; Adams, J; Steel, A

Development and preliminary evaluation of the Conventional Medicine Disclosure Index.

McIntyre, E

Foley, H Harnett, J Adams, J

Steel, A

Permalink

Publisher:: Elsevier BV
Publication Type:: Journal Article
Citation:: Research in social & administrative pharmacy : RSAP, 2021
Issue Date:: 2021-01-31

Closed Access

	Filename	Description	Size
	Development and preliminary evaluation of the Conventional Medicine Disclosure Index.pdf	Published version	2.99 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	McIntyre, E https://orcid.org/0000-0002-3970-9979
dc.contributor.author	Foley, H
dc.contributor.author	Harnett, J
dc.contributor.author	Adams, J https://orcid.org/0000-0002-9901-5717
dc.contributor.author	Steel, A https://orcid.org/0000-0001-6643-9444
dc.date.accessioned	2021-04-15T06:40:54Z
dc.date.available	2021-01-26
dc.date.available	2021-04-15T06:40:54Z
dc.date.issued	2021-01-31
dc.identifier.citation	Research in social & administrative pharmacy : RSAP, 2021
dc.identifier.issn	1551-7411
dc.identifier.issn	1934-8150
dc.identifier.uri	http://hdl.handle.net/10453/148136
dc.description.abstract	<h4>Background</h4>Non-disclosure of conventional medicine use to complementary medicine health professionals may result in patient harm. Currently, no standardised validated instrument is available to measure reasons for conventional medicine disclosure or non-disclosure.<h4>Objective</h4>The aim of this study was to develop and evaluate a multidimensional index for identifying reasons for conventional medicine disclosure and non-disclosure by patients.<h4>Methods</h4>Drawing upon a sub-sample of the Complementary and Alternative Medicine Use Health Literacy Disclosure Study (N = 520), a formative measurement approach was used to develop a Conventional Medicine Disclosure Index (CONMED-DI). Variance-based structural equation modelling employing partial least squares evaluated multicollinearity, significance and relevance of the formative indicators to their associated primary constructs.<h4>Results</h4>The CONMED-DI demonstrated adequate construct validity suggesting the CONMED-DI is a pragmatic measure to determine the reasons why people choose to disclose (or not) their conventional medicine use. The CONMED-DI contains 2 second-order measurement models, both with three sub-domains.<h4>Conclusion</h4>The CONMED-DI serves as a preliminary instrument primarily of value to researchers interested in exploring the complementary medicine clinical encounter. The development of targeted interventions that promote disclosure of conventional medicine can be facilitated through understanding patients' reasons for disclosure and non-disclosure and optimise patients' safe use of medicines.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier BV
dc.relation.ispartof	Research in social & administrative pharmacy : RSAP
dc.relation.isbasedon	10.1016/j.sapharm.2021.01.015
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1115 Pharmacology and Pharmaceutical Sciences, 1117 Public Health and Health Services
dc.subject.classification	Pharmacology & Pharmacy
dc.title	Development and preliminary evaluation of the Conventional Medicine Disclosure Index.
dc.type	Journal Article
utslib.location.activity	United States
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/DVC (Research)
pubs.organisational-group	/University of Technology Sydney/DVC (Research)/Institute For Sustainable Futures
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Public Health
utslib.copyright.status	closed_access	*
dc.date.updated	2021-04-15T06:40:53Z
pubs.publication-status	Published

Abstract:

Background

Non-disclosure of conventional medicine use to complementary medicine health professionals may result in patient harm. Currently, no standardised validated instrument is available to measure reasons for conventional medicine disclosure or non-disclosure.

Objective

The aim of this study was to develop and evaluate a multidimensional index for identifying reasons for conventional medicine disclosure and non-disclosure by patients.

Methods

Drawing upon a sub-sample of the Complementary and Alternative Medicine Use Health Literacy Disclosure Study (N = 520), a formative measurement approach was used to develop a Conventional Medicine Disclosure Index (CONMED-DI). Variance-based structural equation modelling employing partial least squares evaluated multicollinearity, significance and relevance of the formative indicators to their associated primary constructs.

Results

The CONMED-DI demonstrated adequate construct validity suggesting the CONMED-DI is a pragmatic measure to determine the reasons why people choose to disclose (or not) their conventional medicine use. The CONMED-DI contains 2 second-order measurement models, both with three sub-domains.

Conclusion

The CONMED-DI serves as a preliminary instrument primarily of value to researchers interested in exploring the complementary medicine clinical encounter. The development of targeted interventions that promote disclosure of conventional medicine can be facilitated through understanding patients' reasons for disclosure and non-disclosure and optimise patients' safe use of medicines.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/148136